Role of quantitative viral load monitoring of BK virus in hemorrhagic cystitis complicating HSCT patients  by Grantham, K. et al.
other fungi including Penicillium. Methods: We developed a set of
real-time PCR assays for species-speciﬁc detection of 5 medically
important species (A. fumigatus, A. ﬂavus, A. nidulans, A. niger, A.
terreus) that covers 	99% of all Apsergillus infections. In addition
to BLAST analysis, we evaluated cross-reactivity with other As-
pergillus species, and other fungi. Blood specimens were spiked
with serially diluted conidia to establish the dynamic range of
detection. Additionally, to evaluate the clinical utilities of these
assays, we retrospectively analyzed blood from 60 HSCT patients
whose specimens were sent for routine CMV testing. Results: We
identiﬁed individual ITS1 regions that are speciﬁc for each of the
5 Aspergillus species but are conserved among the strains within the
species. Using scorpion technology, each assay ampliﬁed and de-
tected the species-speciﬁc sequence only and no cross-reactivity
was detected when it was challenged with other fungal genomic
DNA. These assays can detect as few as 100 conidia/mL of whole
blood. Of 60 patients analyzed, 2 patients (3%) were Aspergillus-
positive. One patient was positive for A. ﬂavus (1.11 &ttimes; 103
copies/mL), and 1 patient was coinfected with A. ﬂavus (6.40 102
copies/mL) and A. niger (2.70  103 copies/mL). Conclusions:
Developing a real time PCR assay for species-speciﬁc identiﬁcation
of Aspergillus is a major challenge because of signiﬁcant genomic
sequence homology among thousands of common environmental
fungi such as Penicillium. Using scorpion real time PCR assays, we
have identiﬁed Aspergillus infections at the species level in HSCT
patients. Currently, we are evaluating diagnostic utilities of these
assays on retrospective and prospective HSCT patients.
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ROLE OF QUANTITATIVE VIRAL LOAD MONITORING OF BK VIRUS IN
HEMORRHAGIC CYSTITIS COMPLICATING HSCT PATIENTS
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Background: Hemorrhagic cystitis (HC) causes signiﬁcant mor-
bidity in hematopoietic stem cell transplantation (HSCT) patients
that could often be life-threatening in post-engraftment. Its inci-
dence varies from 7 to 68%. Polyoma virus BK (BKV) is known to
be associated with the development of HC, however, its diagnosis
could be difﬁcult. We developed a rapid, sensitive, speciﬁc, and
quantitative real time PCR assay and used it for monitoring BKV
infections in HSCT patients with HC. Methods: Primers and a
TaqMan® probe were designed to speciﬁcally amplify and detect
an 83-bp fragment of the BKV Agno gene. We used this assay to
detect and monitor BKV infections in 421 clinical specimens from
86 BMT patients with HC. Results: The real time quantitative
BKV PCR assay is speciﬁc and does not cross-react with other
viruses. Out of 421 clinical specimens from 86 BMT patients, 134
plasma specimens were from 35 patients, 283 urine specimens were
from 78 patients, 4 tissue specimens were from 4 patients, and 27
patients had both urine and plasma specimens. Overall 288 (68%)
specimens from 65 patients (76%) were positive for BKV. More
speciﬁcally, out of 35 patients with plasma specimens, 18 (51%)
had viremia, and out of 78 patients with urine specimens, 62 (79%)
had viruria. Of the 27 patients with both plasma and urine, 14
(52%) had both viruria and viremia, and 12 (44%) had viruria. Two
patients with viruria and viremia also had BKV in tissue, while
another 2 patients with viruria, but not viremia, were negative in
tissue. Urine viral loads (range 2.5  102–9.9  107, mean 7.7 
107, median 1.6  106) were signiﬁcantly higher than plasma
(range 4.0  102–1.5  106, mean 1.2  106, median 6.1  104).
Nineteen patients with HC serially monitored for BKV infections
for over 3 months showed correlations between BKV loads and
clinical symptoms. Interestingly, 4 patients had viruria with in-
creasing BKV loads that ended up with viremia later, indicating
that early BKV screening of urine may provide an early diagnosis
so that treatment therapy can be instituted to avoid severe HC
complications in HSCT patients. Conclusions: Real time BKV
PCR assay provides a rapid, sensitive, and speciﬁc diagnosis of
BKV infections in HC complicating HSCT patients. Furthermore,
quantitative monitoring helps in determining the severity of infec-
tions and measuring the effectiveness of treatment therapy. Cur-
rently, we are monitoring BKV infections in a controlled study on
HSCT patients with HC.
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COMPARISON OF HEATH-RELATED QUALITY OF LIFE IN SIBLING AL-
LOGENEIC TRANSPLANT DONORS USING BONE MARROW OR PERIPH-
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Purpose: We have programmed a study to evaluate the differ-
ence in health-related quality of life (QOL) in stem cell transplant
donors harvested by marrow aspiration (BM) or by blood apheresis
after peripheral stem cell mobilization with G-CSF (PB). Meth-
ods: Seventy-four healthy sibling donors from 6 institutes entered
the study. The method of harvest was voluntarily selected by each
donor after information about risks and beneﬁts of both proce-
dures. Standard laboratory tests and subjective QOL assessments
by Short-Form 36 (SF36) were performed 4 times; on the day
before operation or G-CSF administration, the seventh day, the
fourth week, and 3 months after harvest. SF 36 includes 8 catego-
ries of assessment; physical functioning (PF), role-physical (RP),
role-emotional (RE), body pain (BP), general health perception
(GH), vitality (VT), social functioning (SF), and mental health
(MH). Results: Thirty-two BM donors and 42 PB donors entered.
When QOL assessments before procedure were compared, scores
of PF, RP, BP, SF, RE, and MH were lower (P  .05, by Mann-
Whitney test) in BM donors than in PB ones. Lowest scores of
QOL were observed on the seventh day after procedures in both
groups. Statistical differences of scores were signiﬁcant in PF
(65.7  10.2 vs 90.8  14.5), RP (50.5  27.9 vs 83.8  22.2), RE
(54.5  30.2 vs 85.1  19.9), VT (54.4  23.2 vs 68.0  25.1), SF
(61.5 26.5 vs 84.6 20.1), and MH (67.6 19.6 vs 78.8 16.0)
between two groups (BM vs PB, respectively). Scores of QOL
returned to the base value at the fourth week in both groups. QOL
scores of PF, RP, SF, and MH were higher than the base value by
paired t-test in BM donors at 3 months after harvest. Discussion:
Previous blood storage and mental stress before anesthesia and
operation appeared to be the causes of decrease in QOL scores
before harvest in BMT donors. Decrease in scores of PF, RP, BP,
and RE at the seventh day indicates both procedures provide
physical stress on donors, however, grade of decrease was higher in
BM donors than in PB donors.Conclusions: BM donors feel more
stress on emotion and mental health as well as physical condition
than PB donors.
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EXTRACORPOREAL PHOTOPHERESIS (ECP) IN CHILDREN WITH RE-
FRACTORY CHRONIC GVHD: FEASIBILITY AND EFFICACY
Browning, B.1, Collins, J., Thormann, K.1, Duerst, R.1, Kletzel, M.1,
Jacobsohn, D.1 Northwestern University / Children’s Memorial Hospi-
tal, Chicago, IL.
Since 2003, we have used ECP for salvage therapy of pediatric
cGVHD. We developed an algorithm for children of different
weights to guide the need for pRBC transfusion prior to ECP: if
	40 kg, transfuse for hematocrit (hct) 26%; if 25–40 kg, trans-
fuse for hct 32%, if 25 kg, transfuse for hct 35%. Extracor-
poreal Volume (ECV) is graphed and maximum number of cycles
and bowl size is determined. Generally, the 125 mL bowl is used.
Patients 25 kg receive NS bolus prior to ﬁrst cycle and prior to
second cycle as needed. Volume of NS bolus is calculated as
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